第一代抗精神病药物是日本制药工业通往第二代抗精神病药物的桥梁:莫沙帕明、替米培龙、佐替平和奈莫那必利

{"title":"第一代抗精神病药物是日本制药工业通往第二代抗精神病药物的桥梁:莫沙帕明、替米培龙、佐替平和奈莫那必利","authors":"K. Inada, M. Murasaki, J. Ishigooka","doi":"10.1007/978-3-319-56015-1_417-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19161,"journal":{"name":"NeuroPsychopharmacotherapy","volume":"99 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First-Generation Antipsychotics as a Bridge to Second-Generation Antipsychotics in the Japanese Pharmaceutical Industry: Mosapramine, Timiperone, Zotepine, and Nemonapride\",\"authors\":\"K. Inada, M. Murasaki, J. Ishigooka\",\"doi\":\"10.1007/978-3-319-56015-1_417-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19161,\"journal\":{\"name\":\"NeuroPsychopharmacotherapy\",\"volume\":\"99 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NeuroPsychopharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-319-56015-1_417-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroPsychopharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-319-56015-1_417-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}